Pentoxifylline in Children With Malaria

NCT00133393 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

50

Enrollment

NIH

Sponsor class

Conditions

Plasmodium Falciparum Malaria

Interventions

DRUG: Pentoxifylline

Sponsor

National Institute of Allergy and Infectious Diseases (NIAID)